Riskpilot← Back to searchSign inGet full accessSVF Vaccines AB
ABActiveOrg 5590019823Nanna Svartz Väg 6 AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20150 employees
Revenue 2024
SEK 0
EBITDA margin
—
+3% vs 2023
Equity ratio
27.3%
Financial strength
Net profit 2024
SEK -8,2M
-7% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -6,8M | +3% |
| Net profit | SEK -8,2M | -7% |
| Total assets | SEK 948K | -72% |
| Equity | SEK 259K | -85% |
| Employees | 0 | — |
Legal name
SVF Vaccines AB
Org number
5590019823
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
28 januari 2015
Share capital
SEK 84 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av Öhd, John Fredrik i förening med en av ledamöterna
Company purpose
Aktiebolaget ska bedriva forskning och utveckling inom det medicinska området, marknadsföra och försälja medicinska tjänster och produkter även som idka annan därmed förenlig verksamhet.
Address
Nanna Svartz Väg 6 A
Email
richard.bethell@svfvaccines.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 179 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −130 | −1 574 | −10 757 | −7 031 | −6 849 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −130 | −1 574 | −10 757 | −7 031 | −6 849 |
| Net financials | — | — | — | −663 | −1 358 |
| Profit before tax | −130 | −1 574 | −10 757 | −7 693 | −8 206 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −130 | −1 574 | −10 757 | −7 693 | −8 206 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 470 | 5 176 | 1 932 | 3 444 | 948 |
| Equity | 431 | 4 857 | 334 | 1 739 | 259 |
| Long-term debt | 0 | 0 | 136 | 136 | 136 |
| Short-term debt | 39 | 319 | 1 461 | 1 569 | 553 |
| Total debt | 39 | 319 | 1 597 | 1 705 | 689 |
EBITDA margin
-684900000.0%
This company
15.8%
Market median
-4334810227% vs market
20202024
Equity ratio
27.3%
This company
38.2%
Market median
-29% vs market
20202024
Return on equity
-3168.3%
This company
18.4%
Market median
-17319% vs market
20202024
Net profit margin
-820600000.0%
This company
8.1%
Market median
-10130864298% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
2.66×
This company
0.62×
Market median
-329% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PS Chief Auditor | Chief Auditor | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2021 | |
| Chairman | 2022 | |
| Board of Directors | 2025 | |
| Board of Directors | 2022 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SVF Vaccines AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pontus Stefan Axel Ohlsson | Chief Auditor | 0 companies |
| Lars Frelin | Board of Directors | 0 companies |
| Viktor Drvota | Deputy Board Member | 0 companies |
| John Fredrik Öhd | Chairman | 0 companies |
| Richard Charles Bethell | Board of Directors | 0 companies |
| Matti Sällberg | Board of Directors | 0 companies |
| Jens Åke Bäck | Board of Directors | 0 companies |